Article ; Online: HSV1716 Prevents Myeloma Cell Regrowth When Combined with Bortezomib
2023 Volume 15, Issue 3
Abstract: Multiple myeloma remains largely incurable due to refractory disease; therefore, novel treatment strategies that are safe and well-tolerated are required. Here, we studied the modified herpes simplex virus HSV1716 ( ... ...
Abstract | Multiple myeloma remains largely incurable due to refractory disease; therefore, novel treatment strategies that are safe and well-tolerated are required. Here, we studied the modified herpes simplex virus HSV1716 (SEPREHVIR |
---|---|
MeSH term(s) | Humans ; Animals ; Mice ; Bortezomib/pharmacology ; Bortezomib/therapeutic use ; Multiple Myeloma/drug therapy ; Mice, Inbred C57BL ; Simplexvirus/genetics ; Annexins ; Cell Line, Tumor ; Apoptosis |
Chemical Substances | Bortezomib (69G8BD63PP) ; Annexins |
Language | English |
Publishing date | 2023-02-22 |
Publishing country | Switzerland |
Document type | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2516098-9 |
ISSN | 1999-4915 ; 1999-4915 |
ISSN (online) | 1999-4915 |
ISSN | 1999-4915 |
DOI | 10.3390/v15030603 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.